Juan Tamargo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Cardiovascular Disease

Hypertrophic Cardiomyopathy

Atrial Fibrillation

Coronary Artery Disease

Top Venues

European heart journal. Cardiovascular pharmacotherapy

Proceedings of the National Academy of Sciences of the United States of America

European heart journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Tamargo
After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension. European heart journal. Cardiovascular pharmacotherapy (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Isabelle C Van Gelder, Michiel Rienstra, Karina V Bunting, Ruben Casado Arroyo, Valeria Caso, Harry J G M Crijns, Tom J R De Potter, Jeremy Dwight, Luigina Guasti, Thorsten Hanke, Tiny Jaarsma, Maddalena Lettino, Maja-Lisa Løchen, R Thomas Lumbers, Bart Maesen, Inge Mølgaard, Giuseppe M C Rosano, Prashanthan Sanders, Renate B Schnabel, Piotr Suwalski, Emma Svennberg, Juan Tamargo, Otilia Tica, Vassil B Traykov, Stylianos Tzeis, Dipak Kotecha, null null
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Anabel Cámara-Checa, Marcos Rubio-Alarcón, María Dago, Teresa Crespo-García, Josu Rapún, María Marín, Juan Tamargo, Ricardo Gómez, Ricardo Caballero, Eva Delpón
Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Juan Tamargo
After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Bruna Gigante, Juan Tamargo, Stefan Agewall, Dan Atar, Jurrien Ten Berg, Gianluca Calogero Campo, Elisabetta Cerbai, Christina Christersson, Dobromir Dobrev, Peter Ferdinandy, Tobias Geisler, Diana Adrienne Gorog, Erik Lerkevang Grove, Juan Carlos Kaski, Andrea Rubboli, Sven Wassmann, Håkan Wallen, Bianca Rocca
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis. European heart journal. Cardiovascular pharmacotherapy (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy (2024)
Anabel Cámara-Checa, Marcos Rubio-Alarcón, María Dago, Teresa Crespo-García, Josu Rapún, María Marín, Juan Tamargo, Ricardo Gómez, Ricardo Caballero, Eva Delpón
Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Anabel Cámara-Checa, Marcos Rubio-Alarcón, María Dago, Teresa Crespo-García, Josu Rapún, María Marín, Juan Tamargo, Ricardo Gómez, Ricardo Caballero, Eva Delpón
Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems. Proceedings of the National Academy of Sciences of the United States of America 121 (16) (2024)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Emma Magavern, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Irina Savelieva, Stefano Fumagalli, Rose Anne Kenny, Stefan Anker, Athanase Benetos, Giuseppe Boriani, Jared Bunch, Nikolaos Dagres, Sergio J Dubner, Laurent Fauchier, Luigi Ferruci, Carsten Israel, Hooman Kamel, Deirdre A Lane, Gregory Y H Lip, Niccolò Marchionni, Israel Obel, Ken Okumura, Brian Olshansky, Tatjana S Potpara, Martin K Stiles, Juan Tamargo, Andrea Ungar, Jedrzej Kosiuk, Torben Bjerregaard Larsen, Borislav Dinov, Heidi Estner, Rodrigue Garcia, Francisco Manuel Moscoso Costa, Rachel Lampert, Yenn-Jiang Lin, Ashley Chin, Heliodoro Antonio Rodriguez, Timo Strandberg, Tomasz Grodzicki
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Anabel Cámara-Checa, Francesca Perin, Marcos Rubio-Alarcón, María Dago, Teresa Crespo-García, Josu Rapún, María Marín, Jorge Cebrián, Ricardo Gómez, Francisco José Bermúdez-Jiménez, Lorenzo Monserrat, Juan Tamargo, Ricardo Caballero, Juan Jiménez Jaimez, Eva Delpón
A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family. Proceedings of the National Academy of Sciences of the United States of America 120 (49) (2023)
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan, Péter Ferdinandy, Erik Lerkevang Grove, Bianca Rocca, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Alexander Niessner, Juan-Carlos Kaski, Dobromir Dobrev
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022. European heart journal. Cardiovascular pharmacotherapy (2023)
Maria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, Peter Søgaard, Basil S Lewis, Sven Wassmann, Iris Baumgartner, Claudio Ceconi, Thomas Andersen Schmidt, Juan-Carlos Kaski, Heinz Drexel, Anne Grete Semb, Stefan Agewall, Alexander Niessner, Gianluigi Savarese, Keld Per Kjeldsen, Claudio Borghi, Juan Tamargo, Christian Torp-Pedersen
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy 7 (6) (2022)
Juan Tamargo, Koji Hasegawa, Stefan Agewall
Toward personalized medicine for cardiovascular pharmacotherapy. European heart journal 43 (45) (2022)
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, Jack Charles Barton, Ko Yamamoto, Maki Komiyama, Heinz Drexel, Basil S Lewis, Stefan Agewall, Koji Hasegawa
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Juan Tamargo, Jose Luis Lopez Sendon
Ranolazine: a better understanding of pathophysiology and patient profile to guide treatment of chronic stable angina. Future cardiology (2021)
Juan Tamargo, Stefan Agewall
Fluoroquinolone use and valvular heart disease: is the jury still out? European heart journal 42 (30) (2021)
José Luis Merino, Juan Tamargo
Is It Safe (and When) to Stop Oral Anticoagulation After Ablation for Atrial fibrillation? (Do We Have Enough Evidence to Solve the Dilemma?). Cardiovascular drugs and therapy 35 (6) (2021)